Back to dashboard
All PlansCoverageHigh impact

Voluntary nationwide recall: Betaxolol

UPMC Health Plan·Pharmacy, Internal Medicine, Cardiology +2 more·Pharmacy
Effective date
Sep 29, 2023
We identified it
Aug 7, 2026
Days to comply

Summary

KVK-Tech Inc. is recalling Betaxolol tablets USP 10 mg (NDC 10702-0013-01, lot 17853A, expiry 06/2027) due to contamination with Oxycodone HCl tablets found during packaging. This is a pharmacy/medication safety recall affecting patients on hypertension treatment. The billing team must identify affected prescriptions and coordinate with providers and patients for medication replacement.

Action Required

Action needed
Immediately: Billing team must work with pharmacy and clinical staff to identify all patients with active prescriptions for Betaxolol 10 mg from lot 17853A (NDC 10702-0013-01). Contact affected patients and providers to halt use and arrange replacement medications. Update patient records in billing/EHR system to flag this lot as recalled. Do NOT process claims for this specific lot. Coordinate with pharmacy for return/replacement of affected medication. Provide patients with KVK-Tech contact information (215-579-1842 Ext: 6002) and FDA recall website. Document all recall-related communications in patient charts. No claims processing delays should occur, but ensure medication substitutions are properly authorized and billed under new prescriptions if needed.